Clinical Trial Update: Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating salvage radiation therapy after BCMA CAR-T therapy in relapsed/refractory multiple myeloma. The study is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• BCMA CAR-T therapy (BCMA-targeted chimeric antigen receptor T-cell therapy)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Multiple Myeloma, Plasma Cell Neoplasm | Phase 2 | Status: RECRUITING